With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Research Institute at Nationwide Children's Hospital / Mary Beth Ross, MD/PhD||Young Investigator Grants||2006||Ohio|
|Anti-Angiogenic Effects of BAI Proteins in Neuroblastoma||Children's Hospital of Philadelphia / Naomi Balamuth, MD||Young Investigator Grants||2006||Pennsylvania|
|MTG-16 Regulation by Phosphorylation||Vanderbilt University / Michael Engel, MD, PhD||Young Investigator Grants||2006||Tennessee|
|Mediators of Metastasis in Alveolar Rhabdomyosarcoma.||University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD||Young Investigator Grants||2006||Texas|
|New Approaches to Neuroblastoma Therapy (NANT) Consortium||Children's Hospital Los Angeles / Robert Seeger, MD||Phase I/II Infrastructure Grants||2006||California|
|Expanding Access to New Agents for Cancer Treatment.||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2006||Colorado|
|CHOA Experimental Therapy Pediatric Oncology Research.||Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta / Howard Katzenstein, MD||Phase I/II Infrastructure Grants||2006||Georgia|
|Pediatric Oncology Translational Research Program.||Vanderbilt University / James Whitlock, MD||Phase I/II Infrastructure Grants||2006||Tennessee|
|Building a Texas-based center for neuroblastoma clinical research.||Baylor College of Medicine / Heidi Russell, MD||Phase I/II Infrastructure Grants||2006||Texas|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|